Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Amedisys Inc (AMED)

Amedisys Inc (AMED)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,930,177
  • Shares Outstanding, K 32,255
  • Annual Sales, $ 1,663 M
  • Annual Income, $ 119,350 K
  • 60-Month Beta 1.38
  • Price/Sales 2.93
  • Price/Cash Flow 35.42
  • Price/Book 8.08

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate 0.93
  • Number of Estimates 8
  • High Estimate 1.01
  • Low Estimate 0.88
  • Prior Year 0.91
  • Growth Rate Est. (year over year) +2.20%

Price Performance

See More
Period Period Low Period High Performance
1-Month
127.12 +21.87%
on 10/31/19
155.78 -0.55%
on 11/18/19
+19.66 (+14.53%)
since 10/18/19
3-Month
121.00 +28.03%
on 10/07/19
155.78 -0.55%
on 11/18/19
+21.90 (+16.46%)
since 08/16/19
52-Week
103.76 +49.31%
on 12/24/18
155.78 -0.55%
on 11/18/19
+29.01 (+23.04%)
since 11/16/18

Most Recent Stories

More News
Amedisys Partners With nVoq to Improve Clinician Experience

Amedisys (AMED) aims to enhance clinician workflow by integrating nVoq's technology platform into its home health business.

HAE : 119.12 (-1.12%)
RMD : 147.78 (+0.46%)
NUVA : 72.59 (-1.06%)
AMED : 154.92 (+1.35%)
3 Reasons Growth Investors Will Love Amedisys (AMED)

Amedisys (AMED) is well positioned to outperform the market, as it exhibits above-average growth in financials.

AMED : 154.92 (+1.35%)
Amedisys to Present at the 2019 Jefferies London Healthcare Conference

Amedisys, Inc. (NASDAQ: AMED), one of America's leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, President and Chief Executive Officer, will present at the...

AMED : 154.92 (+1.35%)
nVoq and Amedisys Collaborate to Enhance the Clinician Experience

nVoq, a leading provider of HIPAA compliant speech recognition solutions for the healthcare industry, is pleased to announce its partnership with Amedisys, Inc. (NASDAQ: AMED), America's leading independent...

AMED : 154.92 (+1.35%)
Amedisys Expanding Commitment to End-of-Life Care for Veterans

Amedisys Inc. (NASDAQ:AMED), a leading independent home health, hospice and personal care company, is taking the opportunity on this Veteran's Day to expand its commitment to honor America's dying military...

AMED : 154.92 (+1.35%)
Is Amedisys (AMED) a Great Growth Stock?

If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider Amedisys (AMED).

AMED : 154.92 (+1.35%)
5 Stocks That Stand Out on Attractive Interest Coverage Ratio

Interest Coverage Ratio is used to determine how effectively a company can pay the interest charges on its debt.

PAM : 12.97 (-1.07%)
LAD : 162.52 (+1.03%)
BLD : 108.92 (+1.52%)
HCA : 136.78 (-0.92%)
AMED : 154.92 (+1.35%)
Amedisys to Present at the 2019 Stephens Nashville Investment Conference

Amedisys, Inc. (NASDAQ: AMED), one of America's leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, President and Chief Executive Officer, will present at the...

AMED : 154.92 (+1.35%)
Media Statement from Amedisys Regarding CY 2020 Home Health Final Rule

Amedisys, Inc. (NASDAQ: AMED), a leading independent home health, hospice and personal care company, is pleased to learn that the Centers for Medicare and Medicaid Services (CMS) has chosen to not finalize...

AMED : 154.92 (+1.35%)
Amedisys (AMED) Soars to 52-Week High, Time to Cash Out?

Amedisys (AMED) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

AMED : 154.92 (+1.35%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade AMED with:

Business Summary

Amedisys, Inc. is a leading provider of healthcare in the home with a vision of becoming the premiere solution for patients. From home health to hospice to personal care, Amedisys team members provide quality, clinically-distinctive care to patients every year. Amedisys is focused on delivering the care...

See More

Key Turning Points

2nd Resistance Point 157.51
1st Resistance Point 156.22
Last Price 154.92
1st Support Level 153.19
2nd Support Level 151.45

See More

52-Week High 155.78
Last Price 154.92
Fibonacci 61.8% 135.91
Fibonacci 50% 129.77
Fibonacci 38.2% 123.63
52-Week Low 103.76

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar